《大行報告》匯豐研究上調高鑫零售(06808.HK)目標價至2.15元 評級「持有」
匯豐研究發表報告指,高鑫零售(06808.HK)在2023財年的前三個季度的盈利能力和收入均受惠於疫情封城,尤其因家庭囤積,令其線上B2C業務的客單價按年升13%,令全年營運利潤率達1.4%勝於預期。
該行指,管理層對2024財年收入目標為按年持平,但年初至今仍表現落後,管理層認為在短期內要加強其競爭力,在2023財年的毛利率是不能持續的,尤其市場營銷活動在2024財年恢復正常,長遠來看,公司目標透過產品差異化來推動其利潤率。
該行表示,將公司2024財年純利預期下調17%,目標價則由2.02元上調至2.15元,維持「持有」評級。(ca/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.